--- title: 'Phentermine vs Wegovy Comparison Guide: Which Weight‑Loss Option Is Right for You?' date: '2026-07-18' slug: phentermine-vs-wegovy-comparison-guide-which-weightloss-option-is-right-for-you description: Compare phentermine and Wegovy on effectiveness, safety, cost, and lifestyle impact. Learn which fits your goals and how to track Wegovy with a GLP‑1 tracker app. updated: '2026-07-18' author: Dr. Benjamin Paul site: 'Pepio: GLP-1 Peptide Tracker' --- # Phentermine vs Wegovy Comparison Guide: Which Weight‑Loss Option Is Right for You? ## Phentermine vs Wegovy: Understanding the Core Differences Comparing phentermine and Wegovy matters because they differ in how much weight people lose, how long they’re intended to be used, and what they cost. Clinical trials show semaglutide (Wegovy) produced larger average weight loss than phentermine/topiramate in adults with obesity (about 13.7% vs 9.1%) ([Medications for obesity management: Effectiveness and value](https://pmc.ncbi.nlm.nih.gov/articles/PMC10387935/)). Real‑world price comparisons also show Wegovy can cost roughly ten times more per year than a short phentermine course ([GoodRx – Wegovy vs. Phentermine](https://www.goodrx.com/conditions/weight-loss/wegovy-vs-phentermine)). Approval and intended use differ too: phentermine is licensed for short‑term use, while Wegovy is indicated for ongoing weight management ([Medical News Today – Wegovy vs. Phentermine](https://www.medicalnewstoday.com/articles/drugs-wegovy-vs-phentermine)). This guide walks through five decision criteria you can apply: effectiveness, safety, cost, lifestyle impact, and tracking support. Pepio helps you keep the practical side of those questions organized by recording doses, dates, symptoms, and weight progress. Users using Pepio report clearer records to review with clinicians, not medical advice, just better organization. ## Comparison Criteria: What to Evaluate When Choosing a Weight‑Loss Option When comparing weight‑loss options, assess five practical dimensions that drive long‑term success. Pharmacoeconomic reviews use these same criteria to compare value and outcomes ([Pharmacoeconomic Evaluation of Anti‑Obesity Drugs](https://pmc.ncbi.nlm.nih.gov/articles/PMC10658190/)). - Effectiveness: expected weight loss and timeline - Safety: common and serious side effects - Cost: medication price, insurance coverage, and ancillary costs - Lifestyle impact: dosing frequency, administration method, daily routine - Tracking support: need for a dedicated app or tool Effectiveness measures average percent weight loss and the typical 12‑month timeline. Regulators often expect at least a 5% mean reduction versus placebo at one year ([EMA guideline, 2023](https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-evaluation-medicinal-products-used-weight-management-revision-1_en.pdf)). Safety covers common, usually mild side effects and the risk of serious adverse events. Watch for discontinuation rates and how side effects affect daily life and adherence. Cost means yearly retail price, likely out‑of‑pocket cost, and whether insurance covers therapy. Consider added expenses like supplies, clinic visits, or travel costs. Lifestyle impact looks at dosing rhythm, administration method, and storage needs. Some patients prefer daily oral dosing to minimize routine disruption. Tracking support asks whether you need a dedicated app or tool to log doses, symptoms, and weight. Digital tracking may support adherence; Pepio consolidates dose history, symptom notes, and reminders to make routines easier to follow and to reveal clearer trends. Use these five criteria as your checklist when you compare phentermine and Wegovy options. ## Option 1 – Pepio GLP‑1 Tracker App (Ideal for Wegovy Users) Pepio GLP‑1 tracker benefits for Wegovy users: Pepio is a tracking-first app that helps you keep your Wegovy routine organized. It collects shot dates, dose history, symptoms, appetite changes, weight trends, and injection‑site notes in one place. That makes it easier to stay consistent and review progress over time. - All‑in‑one shot logging, dose history, and reminder system - Symptom tracking (including appetite changes) to spot patterns - Weight‑loss progress charts linked to injection dates - Injection‑site rotation log to prevent tissue irritation - Exportable reports for clinician visits Pepio’s role maps directly to common evaluation criteria for people choosing a weight‑loss option. For tracking support, it consolidates shot logs and symptom entries so you stop juggling notes and screenshots. For lifestyle, it ties weight trends to shot dates so you can see patterns around busy weeks or dose changes. For cost, Pepio provides free web tools with zero‑sign‑up and browser‑only storage (privacy‑first) plus a lightweight iOS app—both free to use. You can “Save into Pepio” to sync web entries to the iOS app, and download PDF or CSV exports to bring clear timelines to appointments. Organized digital tracking can support adherence and review with clinicians. Pepio is available as an iOS app, so you can use the free browser tools and the mobile app together ([App Store](https://apps.apple.com/us/app/glp-1-tracker-pep-glp1/id6504788281)). Pepio’s tracking approach helps you stay consistent and build a reliable routine without medical advice. Pepio is for organization and self‑tracking only; always follow your clinician’s instructions. If you want a simple place to keep dose history, symptom notes, and exportable progress reports to share with your clinician, learn more about how Pepio supports Wegovy users and consider tracking your next shot in the app. ## Option 2 – Wegovy (Semaglutide) Injection Therapy Wegovy (semaglutide) is a weekly injectable approved for weight management. STEP 1 showed an average ~15% weight loss at 68 weeks; a substantial subset achieved ≥20% (Novo Nordisk press release). This timeline reflects long‑term treatment rather than a quick fix. Gastrointestinal effects are the most commonly reported side effects. Nausea affected many users, with rates reported at about 44% in the pivotal program. Constipation and vomiting were also common, and there is a small increased risk of gallbladder disease (Wegovy FDA Prescribing Information (2024)). Wegovy is given as a weekly subcutaneous injection. Store unused pens in a refrigerator (2°C–8°C). If needed, each single‑dose pen may be stored at room temperature (≤30°C) for up to 28 days (Wegovy FDA Prescribing Information (2024)). Cost varies widely. The U.S. list price for a 2.4 mg supply is about $1,349 per month, though insured patients often pay much less, commonly in the $25–$200 per month range depending on coverage (Drugs.com – Wegovy Pricing and Insurance). Upfront and ongoing costs can affect adherence and access. Consistent tracking helps you manage the practical details of Wegovy use. Pepio helps you keep a clear record of shot dates, symptoms, storage notes, and weight changes so you can review trends. Users who log doses and side effects with Pepio often bring cleaner notes to follow‑ups. Pepio’s approach supports adherence and better clinician conversations by keeping routine data in one place. Always follow instructions from your clinician, prescriber, pharmacist, or medication label. Pepio is for organization and self‑tracking only, not medical advice. ## Option 3 – Phentermine Oral Tablet When weighing phentermine effectiveness, safety, cost and lifestyle impact, start with its approved use. Phentermine is typically prescribed for short courses, often up to 12 weeks, not for long‑term therapy ([Medical News Today](https://www.medicalnewstoday.com/articles/drugs-wegovy-vs-phentermine)). In practice, short‑term phentermine regimens can yield modest weight loss. Real‑world studies and reviews report average losses commonly in the range of about 3% to 10% of body weight, depending on dose and duration ([Medications for obesity management: Effectiveness and value](https://pmc.ncbi.nlm.nih.gov/articles/PMC10387935/)). This outcome contrasts with longer, maintenance‑focused treatments, which follow different care plans. Phentermine carries common side effects that you should monitor. Users often report increased heart rate, insomnia, dry mouth, and nervousness. There are also concerns about dependence with extended use, and clinicians typically recommend cardiovascular monitoring while on the drug ([Medical News Today](https://www.medicalnewstoday.com/articles/drugs-wegovy-vs-phentermine)). Do not change your dose without clinician guidance. Lifestyle trade‑offs matter. Phentermine is an oral daily tablet, which some people prefer to injections. It is generally less expensive than many newer weight‑loss drugs, but insurance coverage varies ([GoodRx – Wegovy vs. Phentermine](https://www.goodrx.com/conditions/weight-loss/wegovy-vs-phentermine)). You may need regular blood pressure or heart‑rate checks, and you should keep clear records of start dates, stop dates, and side effects. If you track multiple medication types, tools like Pepio help you keep oral and injection routines organized. People using Pepio find it easier to log doses, symptoms, and weight changes across treatments. Learn more about Pepio’s approach to keeping medication routines organized and preparing clean notes for clinician visits. Pepio is for organization and self‑tracking only. Pepio does not provide medical advice or dosing recommendations. ## Side‑by‑Side Comparison Table Quick, scannable comparison across five practical criteria to weigh tracking versus medication choices.
Criterion Pepio Wegovy Phentermine Notes / Sources
Effectiveness N/A (tracking only) High (~15–20% weight loss) Moderate (5–10% weight loss) Semaglutide‑class trials report larger percent weight loss over extended follow‑up; phentermine shows smaller real‑world gains (see clinical reviews).
Safety Tool for organization and self‑tracking only; does not affect health directly Gastrointestinal side effects are common Cardiovascular and central nervous system risks Review medication safety with your clinician and consult clinical reviews for details.
Cost Free web tools + free iOS app ~$1,349/month (list price; out‑of‑pocket varies with insurance and copay programs) $30–$70/month Out‑of‑pocket differences can be large; check current pricing and insurance coverage.
Lifestyle Purpose‑built for GLP‑1 and peptides (injection logging, reminders on iOS, site‑rotation, symptom/weight trends) Weekly injection plus structured program Daily oral pill; may require cardiovascular monitoring Consider injection frequency and monitoring needs when choosing a plan.
Tracking Built‑in GLP‑1 and peptide tracker for dose history, symptoms, and reminders; push notifications on iOS; injection‑site rotation planner; one‑click PDF/CSV export — a purpose‑built companion for GLP‑1 users. See the GLP‑1 Shot Tracker. Users often rely on manual logs or manufacturer resources No dedicated tool Manufacturer companion apps exist for some GLP‑1s, but a purpose‑built tracker keeps your routine in one place.
Use this table to match your tracking needs with medication tradeoffs, and learn how Pepio can help you keep dose history, symptoms, and reminders organized as you discuss options with your clinician. ## Use‑Case Recommendations: Which Option Fits Which Scenario? Wegovy and phentermine serve different goals, and a tracking app like Pepio fills a separate but essential role. Wegovy tends to produce larger, sustained weight loss (roughly 15% at 68 weeks) while phentermine usually yields more modest losses over a short course (about 5–10% over 12 weeks) ([Hone Health](https://honehealth.com/edge/wegovy-vs-phentermine/); [GoodRx](https://www.goodrx.com/conditions/weight-loss/wegovy-vs-phentermine)). Use the scenarios below to match a choice to your situation, then pair that choice with practical tracking and clinician guidance. 1. Scenario 1 – First‑month Wegovy user: Pair Wegovy with Pepio for daily reminders and symptom logs. 2. Scenario 2 – Short‑term appetite control: Phentermine may be appropriate; use Pepio’s symptom and weight logs to track side effects and progress between visits. 3. Scenario 3 – Cost‑sensitive long‑term plan: Use Pepio’s free tools to maximize Wegovy adherence while minimizing extra expenses. From a safety perspective, talk to your clinician before starting or switching medications. Track the dose you were instructed to take, note timing, and record any side effects. If you notice severe or worrying symptoms, seek medical advice right away. Practical next steps: pair medication with a consistent tracking routine, monitor patterns in symptoms and weight, and prepare exportable notes for follow-up visits. Users who adopt Pepio’s approach to routine tracking report easier review of dose history and symptom timelines, and the app is available on the App Store for download ([Pep GLP‑1 Tracker on Apple](https://apps.apple.com/us/app/glp-1-tracker-pep-glp1/id6504788281)). Learn more about Pepio’s approach to GLP‑1 tracking and how organized logs can support clearer clinician conversations and steadier routines. Wegovy tends to deliver larger, longer-term weight loss, while phentermine usually offers lower-cost, short-term results. Whatever you choose, track doses and symptoms; Pepio helps keep routines organized—learn more about Pepio’s approach ([EASO review](https://easo.org/weight-loss-targets-in-obesity-management-is-this-the-wrong-objective/), [App Store](https://apps.apple.com/us/app/glp-1-tracker-pep-glp1/id6504788281)).